| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
ADC Therapeutics SA
13G
ADCT · H0036K147
|
10.0% |
10/29/2026
Event 10/22/2026
|
||||
|
Olema Pharmaceuticals, Inc.
13G/A
OLMA · 68062P106
|
8.2% |
5/15/2026
Event 3/31/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.